Breaking News Headlines Today

News about Novo Nordisk

Stay current with all the latest and breaking news about Novo Nordisk, compare headlines and perspectives between news sources on stories happening today. In total, 160 stories have been published about Novo Nordisk which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Novo Nordisk News

Novo Nordisk · New York

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit

61% Center coverage: 18 sources

/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025...See the Story

Diabetes · Denmark

Novo Nordisk Tells Staff to Return to Office Full-Time

67% Center coverage: 6 sources

Wegovy-maker Novo Nordisk said it had told all its staff to return to the office as the drugmaker's new CEO tries to accelerate decision-making and improve its commercial execution amid intense competition in the obesity drug market.See the Story

Obesity

Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm

67% Left coverage: 3 sources

A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with obesity, including those with type 2 diabetes (T2D), according to the results of two large-scale, international phase 3 clinical trials.See the Story

Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm

67% Left coverage: 3 sources

Novo Nordisk A/S $NVO Shares Bought by Verde Capital Management

Verde Capital Management grew its holdings in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 15.2% during the second quarter, Holdings Channel reports. The firm owned 42,837 shares of the company’s stock after acquiring an additional 5,639 shares during the quarter. Novo Nordisk A/S comprises 0.7% of Verde Capital Management’s portfolio, making the […]Novo Nordisk · Denmark Read Article

14 Biggest Companies Outside the US

When people think about massive corporations, American giants like Apple, Microsoft, and Amazon usually come to mind first. But the global business landscape tells a much bigger story. Companies from every continent have built empires worth hundreds of billions of dollars, dominating everything from oil fields in the Middle East to semiconductor factories in Asia. These international powerhouses prove that innovation and business success aren’t …Saudi Aramco · China Read Article

Pharmalittle: We're reading about FDA adcomms, Kenvue lobbying RFK Jr. about Tylenol, and more

100% Center coverage: 1 sources

Novo Nordisk is calling workers back to the office as the company struggles to catch up with Eli Lilly in the obesity marketRobert F. Kennedy Jr. · United States Read Article

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit

61% Center coverage: 18 sources

/PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025...Novo Nordisk · New York See the Story

Novo Nordisk Tells Staff to Return to Office Full-Time

67% Center coverage: 6 sources

2 Undervalued Healthcare Stocks to Buy in 2025 and Hold for Decades @themotleyfool #stocks $NVO $LLY $DOC

100% Left coverage: 1 sources

Key PointsThe overall stock market keeps reaching new heights, but some of its components are having a lousy year.Novo Nordisk stock has lost more than half its value over the past year despite rapidly growing sales of its anti-obesity treatment.Healthpeak Properties' stock is down because it reduced its dividend to complete a merger last year.10 stocks we like better than Novo Nordisk › Finding undervalued stocks isn't easy these days. The aver…Stock Markets · Denmark Read Article

Novo Nordisk A/S (NYSE:NVO) Trading Up 1.3% Following Analyst Upgrade

Novo Nordisk A/S (NYSE:NVO – Get Free Report)’s share price traded up 1.3% during mid-day trading on Wednesday after Sanford C. Bernstein upgraded the stock from a market perform rating to an outperform rating. The company traded as high as $55.05 and last traded at $55.03. 7,137,751 shares traded hands during mid-day trading, a decline […]Novo Nordisk · Denmark Read Article

Ozempic-Maker Novo and Wind Giant Orsted Made Denmark Rich. Are the Boom Times Now Over?

100% Right coverage: 2 sources

There are fears Denmark is facing a so-called “Nokia risk”. Read more at straitstimes.com.Novo Nordisk · Denmark See the Story

It only Took 3 Weeks and the Result Was Shocking!

We are shocked by the results, says one of the researchers behind the study, Romain Barrés, professor at the University of Copenhagen at the Novo Nordisk Foundation's Center for Basic Metabolic Research. Romy Rohmann. The experiment consisted of giving 43 Danish men between the ages of 20 and 35 different foods for three weeks, and then looking at the results. Videnskab.dk writes this on its website: For three weeks they were given meals that co…Novo Nordisk · Denmark Read Article

News about Novo Nordisk

News about Novo Nordisk

Covered Most By

Local News Publishers

Top Novo Nordisk News

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit

Novo Nordisk Tells Staff to Return to Office Full-Time

Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm

Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm

Novo Nordisk A/S $NVO Shares Bought by Verde Capital Management

14 Biggest Companies Outside the US

Pharmalittle: We're reading about FDA adcomms, Kenvue lobbying RFK Jr. about Tylenol, and more

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit

Novo Nordisk Tells Staff to Return to Office Full-Time

2 Undervalued Healthcare Stocks to Buy in 2025 and Hold for Decades @themotleyfool #stocks $NVO $LLY $DOC

Novo Nordisk A/S (NYSE:NVO) Trading Up 1.3% Following Analyst Upgrade

Ozempic-Maker Novo and Wind Giant Orsted Made Denmark Rich. Are the Boom Times Now Over?

It only Took 3 Weeks and the Result Was Shocking!

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Novo Nordisk

Higher doses of semaglutide can safely enhance weight loss for adults living with obesity, clinical trials confirm

Novo Nordisk A/S $NVO Shares Bought by Verde Capital Management

14 Biggest Companies Outside the US

Pharmalittle: We're reading about FDA adcomms, Kenvue lobbying RFK Jr. about Tylenol, and more

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit

Novo Nordisk Tells Staff to Return to Office Full-Time

2 Undervalued Healthcare Stocks to Buy in 2025 and Hold for Decades @themotleyfool #stocks $NVO $LLY $DOC

Novo Nordisk A/S (NYSE:NVO) Trading Up 1.3% Following Analyst Upgrade

Ozempic-Maker Novo and Wind Giant Orsted Made Denmark Rich. Are the Boom Times Now Over?

It only Took 3 Weeks and the Result Was Shocking!